Beta Bionics, Inc.

NASDAQ:BBNX

Medical - Equipment & Services

Healthcare
$14.33 +3.18%

+$0.42 today

Market cap
$644.70M
Beta
3.39
P/E (TTM)
-9.1
EPS (TTM)
-$1.50
52W Low $8.80High $32.71

Volume 1.38M

Average 0.99M

BBNX Operating Cash Flow

Cash generated by the company's core business operations during the period.

Beta Bionics, Inc.NASDAQ: BBNX

Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Operating cash flow growth accelerates

Q1 FY2026 operating cash flow of $23.83M (cash outflow) rose 19.3% year over year, ahead of the -2.4% change in trailing-twelve-month operating cash flow. Sequentially, it rose 176.2% from the prior quarter. Over 3 fiscal years it compounded at -5.4% a year.

Context

  • Operating cash flow amounted to 50.8% of revenue in FY2025, down 23.3 pp from a year earlier.
  • Operating cash flow grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +19.3% holds above the trailing-twelve-month pace of -2.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$23.83M+176.2% QoQ
Last fiscal yearDec 2025
-$50.93M+5.5% YoY
LTMMar 2026
-$54.78M-2.4% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+19.3%——
1 year+5.5%——
3-year CAGR-5.4%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
(50.93M) USD
Year-over-year change
-5.5%

Operating Cash Flow vs competitors

How BBNX compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -2.4% is the 5th highest of 7, against a peer median of +5.2%.
  • Operating cash flow amounts to 49.7% of revenue for BBNX, versus a peer median of 11.0%.
BBNX Competitors
Operating Cash Flow for BBNX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NVONovo Nordisk A/SLTM Jun 2026DKK 133.01B DKK+9.4%+14.7%40.4%
DXCMDexCom, Inc.LTM Jun 2026$1.75B USD+77.0%+29.1%35.2%
PODDInsulet CorporationLTM Jun 2026$511.2M USD+0.9%+68.5%16.7%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026$105M USD—+220.2%3.3%
BBNXBeta Bionics, Inc.LTM Mar 2026$54.78M USD-2.4%-5.4%49.7%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$19.61M USD+40.6%—1.9%
MNKDMannKind CorporationLTM Mar 2026$18.83M USD-36.0%—5.2%
ORMPOramed Pharmaceuticals Inc.LTM Mar 2026$8.94M USD-14.5%-31.7%—
Peer median (excluding BBNX) —+5.2%+29.1%11.0%

Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(64.75M)(44.1M)(54.76M)(73.2M)
Depreciation & Amortization2.09M2.09M2.28M2.88M
Deferred Income Tax0000
Stock-Based Compensation6.1M5.66M6.38M16.38M
Change in Working Capital(2.79M)(6.36M)(12.15M)(8.99M)
Accounts Receivables0(4.49M)(7.62M)(5.16M)
Inventory0(1.19M)(11.44M)(9.88M)
Accounts Payables(77K)716K1.52M2.1M
Other Working Capital(2.71M)(682K)5.39M3.95M
Other Non-Cash Items(854K)10.27M9.96M12.01M
Operating Cash Flow(60.21M)(32.45M)(48.27M)(50.93M)
Capital Expenditures(772K)(402K)(3.4M)(5.3M)
Acquisitions (Net)0000
Purchases of Investments0(69.3M)(72.13M)(327.51M)
Sales of Investments0072M170M
Other Investing Activities3K(69.29M)50K0
Investing Cash Flow(769K)(69.69M)(3.48M)(162.81M)
Debt Repayment0000
Common Stock Issued389K29K55.62M214.87M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities389K101.03M00
Financing Cash Flow56.78M101.03M55.62M214.87M
Effect of Forex Changes0000
Net Change in Cash(4.2M)(1.11M)3.87M1.14M
Free Cash Flow(60.98M)(32.85M)(51.67M)(56.22M)

Beta Bionics, Inc.

NASDAQ:BBNX

Intrinsic Alpha fair value

Locked

Current Price

$14.33

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.